Ceftriaxone Monotherapy in the Treatment of Low-Risk Febrile Neutropenia

Publisher： Karger

E-ISSN： 1421-9794|44|5|343-354

ISSN： 0009-3157

Source： Chemotherapy, Vol.44, Iss.5, 1998-08, pp. : 343-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospective Study of Empiric Monotherapy with Ceftazidime for Low-Risk Grade IV Febrile Neutropenia after Cytotoxic Chemotherapy in Cancer Patients

By  

Chemotherapy, Vol. 52, Iss. 4, 2006-06 ,pp. : 185-189

Karger

Access to resources Recommend Favorite

Treatment of Febrile Neutropenia with Cefepime Monotherapy

By  

Chemotherapy, Vol. 47, Iss. 3, 2001-04 ,pp. : 226-231

Karger

Access to resources Recommend Favorite

Comparison of Cefepime versus Ceftriaxone-Amikacin as Empirical Regimens for the Treatment of Febrile Neutropenia in Acute Leukemia Patients

By  

Chemotherapy, Vol. 47, Iss. 5, 2001-09 ,pp. : 381-384

Karger

Access to resources Recommend Favorite

Ceftriaxone plus Once Daily Aminoglycoside with Filgrastim for Treatment of Febrile Neutropenia: Early Hospital Discharge vs. Standard In-Patient Care

By  

Chemotherapy, Vol. 45, Iss. 6, 1999-11 ,pp. : 466-476

Karger

Access to resources Recommend Favorite

Ceftriaxone for the Treatment of Febrile Episodes in Nonneutropenic Patients with Hematooncological Disease or HIV Infection: Comparison of Outpatient and Inpatient Care

By  

Chemotherapy, Vol. 47, Iss. 3, 2001-04 ,pp. : 219-225

Karger

Access to resources Recommend Favorite